Dr. Reddy's Laboratories Ltd (RDY) Q1 2027 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to Quarter 1, FY27, early call of Dr. Reddy's Laboratories Ltd. We appreciate your continued interest in our company. I'm Aishwarya Saram, Head of Inventive Relations at Dr. Reddy's. Joining us today are members of the leadership team, Mr. Erez Israeli, our Chief Executive Officer, and Mr. M.V. Larasimham, MDN, our Chief Financial Officer. Our quarterly financial results have been published earlier today and are available on our website for your reference. We will start today's call with MVN providing an overview of our financial performance for the quarter. Following that, Erez will share his insights on key business highlights as well as the company's strategic outlook. We will then open the floor for questions. All commentary and analysis during this call are based on our IFRS consolidated financial statements. Please note that certain non-GAAP financial measures may also be discussed. Recalculations to the corresponding GAAP measures are included in our press release. I would like to remind everyone that the safe harbor provisions outlined in our press release today apply to all forward-looking statements made during this call. Before we proceed, I would like to call out a few housekeeping points. All participants will be in listen-only mode during the opening remarks. Should you need any technical assistance during the call, please use the chat function on your Zoom application. The chat will not be monitored for any questions to the management. The session is being recorded, and both the recording as well as the transcripts will be made available on our website shortly. Please note that this call is a proprietary material of Dr. Reddy's Laboratories Ltd and may not be re-broadcasted or quoted in any media or public forum without prior written consent fr...